Jeffrey Millard
Directeur des opérations chez ENSYSCE BIOSCIENCES, INC.
Profil
Jeffrey Millard is currently the Chief Operating Officer at Ensysce Biosciences, Inc. He started this position in 2019.
He previously worked at Ensysce Biosciences, Inc. as the Chief Operating Officer.
Dr. Millard has an undergraduate degree from Rice University and a doctorate degree from the University of Arizona.
Postes actifs de Jeffrey Millard
| Sociétés | Poste | Début |
|---|---|---|
| ENSYSCE BIOSCIENCES, INC. | Directeur des opérations | 01/01/2019 |
Anciens postes connus de Jeffrey Millard
| Sociétés | Poste | Fin |
|---|---|---|
Ensysce Biosciences, Inc. /Old/
 Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA. | Directeur des opérations | - |
Formation de Jeffrey Millard
| Rice University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENSYSCE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Ensysce Biosciences, Inc. /Old/
Ensysce Biosciences, Inc. /Old/ Medical DistributorsDistribution Services Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA. | Distribution Services |
